Intelligent Bio Solutions (INBS) Operating Margin (2019 - 2024)
Intelligent Bio Solutions has reported Operating Margin over the past 6 years, most recently at 358.55% for Q1 2024.
- Quarterly results put Operating Margin at 358.55% for Q1 2024, up 107308.0% from a year ago — trailing twelve months through Mar 2024 was 359.87% (up 14883.0% YoY), and the annual figure for FY2023 was 1002.11%, down 46914.0%.
- Operating Margin for Q1 2024 was 358.55% at Intelligent Bio Solutions, down from 260.63% in the prior quarter.
- Over the last five years, Operating Margin for INBS hit a ceiling of 174.89% in Q2 2022 and a floor of 9158.69% in Q1 2021.
- Median Operating Margin over the past 5 years was 603.65% (2022), compared with a mean of 1265.42%.
- Biggest five-year swings in Operating Margin: skyrocketed 21319908bps in 2020 and later plummeted -727846bps in 2021.
- Intelligent Bio Solutions' Operating Margin stood at 324.1% in 2020, then plummeted by -502bps to 1949.84% in 2021, then soared by 69bps to 597.45% in 2022, then surged by 56bps to 260.63% in 2023, then plummeted by -38bps to 358.55% in 2024.
- The last three reported values for Operating Margin were 358.55% (Q1 2024), 260.63% (Q4 2023), and 317.35% (Q3 2023) per Business Quant data.